FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain
'They are starting to move more quickly and we would just like to continue to see bold action being taken.'
The dry-run was being conducted in state capitals in at least three session sites. Some states also included districts that are situated in difficult terrain or have poor logistical support, according to officials.
Firms with strong cash flows not happy with 25% public shareholding rule.
HCL Technologies Ltd, India's No. 4 IT services exporter, beat expectations with a 41.6 percent rise in quarterly profit, after order wins boosted earnings.
Interacting with state chief ministers, Modi underscored the enormity of what he described as the world's biggest vaccination exercise, which begins from January 16, saying over 30 crore citizens will get the jabs in the next few months in India against only 2.5 crore people vaccinated so far in over 50 countries in around a month.
Loud applause and cheers rang out as the first jabs were administered to frontline workers at hospitals and healthcare centres across the country on Saturday at the start of the gargantuan COVID-19 vaccination exercise, hailed as a 'momentous' occasion in India's fight against the pandemic.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
The drug that it would supply is called Olanzapine, used to treat schizophrenia and bipolar disorder.
Layoffs are turning out to be the flavour of the week, with European auto makers Peugeot, Citroen and Rolls Royce, British pharma giant AstraZeneca and American defence equipment manufacturer Boeing all set to slash nearly 7,000 jobs.
According to the World Health Organisation, 10 candidate vaccines for COVID-19 are in the clinical evaluation and 126 are in the pre-clinical stage.
Besides Novartis, the other companies are Roche, J&J, Glaxo and Astrazeneca.
As India's largest drugmaker unveiled a deal worth up to $4.6bn to sell control to Daiichi Sankyo of Japan, the disbelief at the press conference was palpable.
India 's airline sector is expected to report losses of $1bn for the year ended last month - double that of a year earlier, according to the head of one of the country's biggest airlines. Naresh Goyal, founder and chairman of Jet Airways, said he expected high costs and fierce price wars to prompt more consolidation in the industry and Jet was ready to seize the opportunity to acquire rivals in India and overseas.
'The government had a vaccine from January.' 'The government should have given the vaccine to all population above the age of 45, right from the start.' 'Each state has its own problems, but as far as vaccine coverage in India is concerned, there have been mistakes.'
The first COVID-19 vaccine shots in India were given on Saturday to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the world's largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.
'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'
US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.
Take the Rediff Business Quiz and see if you know which are the world's top steel, pharma, wine comapnies.
'It is absolutely important for us to continue to message to people that they must wear masks, keep physical distancing, as much as is practically possible, at work or at home.'
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'
Some investors warned of a coming British or even global recession as sterling collapsed to hit its lowest since 1985.
'Essentially there are three things the government should be doing: Identify who you are going to get your vaccine from, figure out how you are going to pay for it, and figure out how you're going to deliver it and to whom.'
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The targeted budget for the project was reportedly projected at 750,000.
Metal stocks were trading under pressure while IT, auto, realty stocks gained in today's deals
Compared to their Indian peers, MNCs have higher return ratios.
FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte
Maruti Suzuki, Asian Paints, L&T, ONGC and Infosys have gained between 1%-1.5%.
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
Launches cloud-based version of solution to target mid-size clients in life sciences.
Investors will maintain a cautious stance.
Britain's vote to leave the European Union means uncertainty for markets and companies as London initiates at least two years of negotiations with the EU.
Short-covering and the propping up of net asset values have potential to boost frontline as well as second-rung names next week
Investors cheered a sharp decline in the Current Account Deficit, which stands at a 4 year low as exports picked up and gold imports reduced.
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
The 30-share Sensex ended up 292 points at 29,571 and the 50-share Nifty closed up 75 points at 8,910.
Sensex, Nifty end the day in red on unfavourable cues from global markets.
Sensex eneded lower on poor perfromance by financials and IT stocks.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances